References
- Braunwald E., Antman E. M., Beaseley J. W., Califf J. M., Cheitlin M. D., Hochman J. S., et al. ACC/AHA guideline update for the management of patients with unstable angina and non‐ST‐segment elevation myocardial infarction‐2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation 2002; 106: 1893–900
- Bertrand M. E., Simmoons M. L., Fox K. A., Wallentin L. C., Hamm C. W., McFadden E., et al. Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevations; recommendations of the TASK force of the European Society of Cardiology. Eur Heart J 2000; 21: 1406–32
- Herbert J. M., Frechel D., Valler E., Kieffer G., Gouy D., Berger Y. Clopidogrel, a novel antiplatelet and antithrombotic drug. Cardiovasc Drug Rev 1993; 11: 180–98
- The CURE Investigators. Effects of clopidogrel in addition to aspirin in patients with acue coronary syndromes without ST‐segment elevation. N Engl J Med 2001; 345: 494–502
- Steinhubl S. R., Berger P. B., Mann J. T., Fry E. T. A., DeLago A., Wilmer C., et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002; 288: 2411–20
- Budaj A., Yusuf S., Metha S. R., Fox K. A. A., Tognoni G., Zhao F., et al. for the CURE Trial investigators. Benefit of clopidogrel in patients with acute coronary syndromes without ST‐segment elevation in various risk groups. Circulation 2002; 106: 1622–6
- Zeymer U., Gitt A. K., Jünger C., Heer T., Wienbergen H., Koeth O., et al. Effect of clopidogrel on 1‐year mortality in hospital survivors of acute ST segment elevation myocardial infarction with or without reperfusion therapy in clinical practice. Eur Heart J 2006; 27: 2661–6
- D'Agostino R. B., Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non‐randomized control group. Stat Med 1998; 17: 2265–81
- Yusuf S., Mehta S. R., Zhao F., Gersh B. J., Commmerford P. J., Blumenthal M., et al. Early and late effects of clopidogrel in patients with acute coronary syndromes. Circulation 2003; 107: 966–72
- Mehta S. R., Yusuf S., Peters R. J., Bertrand M. E., Lewis B. S., Natarajan M. K., et al. Effects of pretreatment with clopidogrel and aspirin followed by long‐term therapy in patients undergoing percutaneous coronary intervention: the PCI‐CURE study. Lancet 2001; 358: 527–33